Table 1 Basic characteristics of the study population
From: Motivations for participating in a clinical trial on an avian influenza vaccine
Number | Percentage | ||
|---|---|---|---|
Gender | |||
Woman | 204 | (56.0) | |
Man | 160 | (44.0) | |
Age † | |||
18 to 24 | 80 | (22.0) | |
25 to 44 | 161 | (44.4) | |
45 to 60 | 92 | (25.3) | |
> 61 | 30 | (8.3) | |
Education level | |||
Non-university | 95 | (26.0) | |
University | 269 | (73.9) | |
Profession † | |||
Health | 138 | (38.7) | |
Non-health | 123 | (34.5) | |
Inactive | 96 | (26.9) | |
Knowledge of the study † | |||
Word of mouth | 255 | (70.1) | |
Talks | 35 | (9.6) | |
Posters/pamphlets | 33 | (9.1) | |
Communication media | 14 | (3.8) | |
Others | 18 | (4.9) | |
Main motivation for participating in the trial | |||
Collaboration with science | 155 | (42.6) | |
Influence of other people | 137 | (37.6) | |
Protection against pandemic | 57 | (15.7) | |
Coverage of expenses | 15 | (4.1) | |
Willingness to participate in a similar study in the future | |||
No | 15 | (4.1) | |
Yes | 318 | (87.4) | |
DK/DA‡ | 31 | (8.5) | |